{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:51:00Z","timestamp":1770749460257,"version":"3.50.0"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T00:00:00Z","timestamp":1646697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>This study sought to determine the potential change in trends in the baseline characteristics of patients with symptomatic severe mitral regurgitation who underwent transcatheter edge-to-edge mitral valve repair (M-TEER) over the last decade in a high-volume center.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methodology<\/jats:title><jats:p>The investigation included 942 symptomatic patients with moderate-to-severe and severe mitral regurgitation who underwent transcatheter edge-to-edge repair (TEER) at our institution between January 2010 and March 2021. Patients were divided into quintiles and compared separately.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Patients treated in the last quintile had significantly lower surgical risk (Euro Score 7.2 \u00b1 6.8% in the last quintile vs. 10.9 \u00b1 9.4% in the first quintile, <jats:italic>p<\/jats:italic> &amp;lt; 0.001), better New York Heart Association (NYHA) status (NYHA IV 14% in the last quintile vs. 40% in the first quintile, <jats:italic>p<\/jats:italic> &amp;lt; 0.001), lower NT-pro-BNP, and smaller left ventricle diameter than patients who were treated in the first quintile. There was no difference in age between quintiles. However, an invasive hemodynamic assessment did not show significant changes over the last decade (sPAP 51.35 \u00b1 16.2 mmHg in the first quintile vs. 51.02 \u00b1 14.5 mmHg in the last quintile, <jats:italic>p<\/jats:italic> = 0.90, pulmonary capillary wedge V wave 30.7 \u00b1 14.8 mmHg in the first quintile vs. 27.4 \u00b1 10.3 mmHg in the last quintile, <jats:italic>p<\/jats:italic> = 0.40). There is a significant trend of a gradually increasing proportion of patients with degenerative mitral regurgitation (MR) over the last 10 years (<jats:italic>p<\/jats:italic> &amp;lt; 0.001). The experience gained in the M-TEER procedure brought a significant reduction in fluoroscopy time and hospitalization duration. Medical therapy significantly changed over the last decade in terms of higher use of angiotensin receptor blockers (ARBs), lower use of angiotensin-converting enzyme inhibitors (ACEIs), and the introduction of angiotensin receptor-neprilysin inhibitors (ARNIs).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Patients undergoing the M-TEER procedure nowadays have lower surgical risk and are treated before they develop a significant left ventricular (LV) remodeling than before. The increasing expertise on the procedure over the last decade led to a rising number of patients with complex degenerative pathology being treated.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2022.850356","type":"journal-article","created":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T07:28:37Z","timestamp":1646724517000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Trends in Transcatheter Edge-to-Edge Mitral Valve Repair Over a Decade: Data From the MiTra ULM Registry"],"prefix":"10.3389","volume":"9","author":[{"given":"Nicoleta","family":"Nita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonhard","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tilman","family":"Dahme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinisa","family":"Markovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjam","family":"Ke\u00dfler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfang","family":"Rottbauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marijana","family":"Tadic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"ehab395","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"28","author":"Vahanian","year":"2021","journal-title":"Eur Heart J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1016\/j.rec.2017.12.013","article-title":"2017 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.jacc.2009.03.077","article-title":"Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort","volume":"54","author":"Feldman","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","article-title":"Transcatheter mitral-valve repair in patients with heart failure","volume":"379","author":"Stone","year":"2018","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1056\/NEJMoa1805374","article-title":"Percutaneous repair or medical treatment for secondary mitral regurgitation","volume":"379","author":"Obadia","year":"2018","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/icvts\/ivr072","article-title":"Mortality from isolated coronary bypass surgery: a comparison of the Society of Thoracic Surgeons and the EuroSCORE risk prediction algorithms","volume":"14","author":"Qadir","year":"2012","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1136\/heartjnl-2017-312605","article-title":"Five-year outcomes of transcatheter reduction of significant mitral regurgitation in high-surgical-risk patients","volume":"105","author":"Kar","year":"2019","journal-title":"Heart"},{"key":"B8","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.jcmg.2020.05.042","article-title":"Impact of proportionality of secondary mitral regurgitation on outcome after transcatheter mitral valve repair","volume":"14","author":"Orban","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e0251463","DOI":"10.1371\/journal.pone.0251463","article-title":"Safety, effectiveness and costs of percutaneous mitral valve repair: a real-world prospective study","volume":"16","author":"Willits","year":"2021","journal-title":"PLoS ONE"},{"key":"B10","first-page":"E313","article-title":"Mid-term clinical outcomes following percutaneous mitral valve edge-to-edge repair","volume":"32","author":"Demir","year":"2020","journal-title":"J Invasive Cardiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/joic.12557","article-title":"Continuous invasive hemodynamic monitoring using steerable guide catheter to optimize mitraclip transcatheter mitral valve repair: a multicenter, proof-of-concept study","volume":"31","author":"Tang","year":"2018","journal-title":"J Interv Cardiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s11886-020-01305-1","article-title":"The PASCAL device-early experience with a leaflet approximation device: what are the benefits\/limitations compared with the MitraClip?","volume":"22","author":"Corpataux","year":"2020","journal-title":"Curr Cardiol Rep"},{"key":"B13","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.rec.2019.06.002","article-title":"Safety and outcomes of MitraClip implantation in functional mitral regurgitation according to degree of left ventricular dysfunction","volume":"73","author":"Sanchis","year":"2020","journal-title":"Rev Esp Cardiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/S0140-6736(17)31600-8","article-title":"Compassionate use of the PASCAL transcatheter mitral valve repair system for patients with severe mitral regurgitation: a multicentre, prospective, observational, first-in-man study","volume":"390","author":"Praz","year":"2017","journal-title":"Lancet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ejim.2020.02.019","article-title":"Percutaneous mitral valve repair for secondary mitral valve regurgitation: a systematic review and meta-analysis","volume":"78","author":"Kumar","year":"2020","journal-title":"Eur J Intern Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jchf.2019.02.015","article-title":"Outcomes and effect of treatment according to etiology in HFrEF: an analysis of PARADIGM-HF","volume":"7","author":"Balmforth","year":"2019","journal-title":"JACC Heart Fail"},{"key":"B17","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.jacc.2020.05.072","article-title":"Effect of Sacubitril\/Valsartan on biomarkers of extracellular matrix regulation in patients with HFpEF","volume":"76","author":"Cunningham","year":"2020","journal-title":"J Am Coll Cardiol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.850356\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T07:28:40Z","timestamp":1646724520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.850356\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,8]]},"references-count":17,"alternative-id":["10.3389\/fcvm.2022.850356"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.850356","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,8]]},"article-number":"850356"}}